Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Items 1-10 of 85

Page
per page
  1. Tankyrase Inhibitors (TNKS) 49
    A8601 Tankyrase Inhibitors (TNKS) 49
    Target: Tankyrases
    Summary: Tankyrase inhibitor
      ≥22.45 mg/mL
  2. CUDC-907
    A4097 CUDC-907
    Target: Histone Deacetylases (HDACs)|PI3K
    Summary: Potent PI3K/HDAC inhibitor
      ≥25.45 mg/mL
  3. PCI-34051
    A4091 PCI-34051
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC8 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥14.8 mg/mL
  4. MC1568
    A4094 MC1568
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Class II HDAC inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥15.7 mg/mL
  5. ITF2357 (Givinostat)
    A4093 ITF2357 (Givinostat)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      ≥23.8 mg/mL
  6. Valproic acid sodium salt (Sodium valproate)
    A4099 Valproic acid sodium salt (Sodium valproate)
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      ≥8.35 mg/mL
  7. Fostriecin sodium salt
    A4536 Fostriecin sodium salt
    Target: PP1|PP2A|Topoisomerases|PP4
    Summary: Antitumor antibiotic
      Soluble in H2O
  8. EX 527 (SEN0014196)
    A4181 EX 527 (SEN0014196)
     1 Citation
    Target: Sirtuin
    Summary: SIRT1 inhibitor
      insoluble in H2O; ≥12.43 mg/mL
  9. GSK1324726A
    B1013 GSK1324726A
    Target: Bromodomains
    Summary: BET proteins inhibitor
  10. Tenovin-6
    A8302 Tenovin-6
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT inhibitor and p53 activator
      ≥22.75 mg/mL

Items 1-10 of 85

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
  2. Specificity Selective Remove This Item
  3. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 6item
  2. Aurora Kinase 10item
  3. DNA Methyltransferase 3item
  4. HDAC 25item
  5. Histone Acetyltransferases 2item
  6. Histone Demethylases 2item
  7. Histone Methyltransferase 11item
  8. HIF 3item
  9. JAK 11item
  10. PARP 5item
  11. Pim 2item
  12. Protein Ser/Thr Phosphatases 2item
  13. Sirtuin 3item
  14. Sphingosine Kinase-2 1 item
Reversibility
  1. Reversible 6item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 23item
  3. PI3K 1 item
  4. Aurora Kinases 10item
  5. EZH2 2item
  6. Bromodomains 4item
  7. FLT3 1 item
  8. Hydrolase 1 item
  9. DOT1L 3item
  10. Nrf2 1 item
  11. Pim 2item
  12. Sir2-like Family Deacetylases (Sirtuins) 2item
  13. PP1 1 item
  14. PP2A 1 item
  15. STAT 1 item
  16. Hypoxia Inducible Factors (HIFs) 2item
  17. Tankyrases 1 item
  18. JAK 10item
  19. p300 1 item
  20. Syk 1 item
  21. EZH1 1 item
  22. TNKS 1 item
  23. Topoisomerases 1 item
  24. DNA Methyltransferases 2item
  25. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  26. CREBBP 1 item
  27. EP300 1 item
  28. PARP 3item
  29. Bromodomain and Extra-Terminal motif (BET) 1 item
  30. phosphatases 1 item
  31. G9a 1 item
  32. AChE 1 item
  33. Catechol O-Methyltransferase (COMT) 1 item
  34. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  35. Protein Arginine Methyltransferases 1 item
  36. Cytidine deaminases 1 item
  37. PP4 1 item
  38. c-RET 1 item
  39. HDAC 1 item
  40. TYK2 1 item
  41. LSD 1 item
  42. PRMT 1 item
  43. GLP 1 item
  44. SK 1 item
  45. Sirtuin 1 item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 8item
  3. Bladder Cancer 2item
  4. Bladder Carcinoma 1 item
  5. Breast Cancer 16item
  6. Cancer 56item
  7. Castration-resistant Prostate Cancer 1 item
  8. Cervical Cancer 1 item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Colon Cancer 9item
  11. Colon Carcinoma 1 item
  12. Colorectal Cancer 4item
  13. Diffuse Large B-cell Lymphoma 1 item
  14. Dyskinesia 1 item
  15. Epilepsy 1 item
  16. Friedreich's Ataxia 1 item
  17. Glioblastoma 2item
  18. Glioma 2item
  19. Hepatic Cancer 1 item
  20. Hepatocellular Carcinoma 1 item
  21. HIV Infections 2item
  22. Immunological Diseases 1 item
  23. Inflammatory Bowel Disease 1 item
  24. Inflammatory Diseases 2item
  25. Leukemia 7item
  26. Lung Cancer 6item
  27. Lymphoma 5item
  28. Melanoma 3item
  29. Mixed Lineage Leukemia 3item
  30. Multiple Myeloma 5item
  31. Myelofibrosis 1 item
  32. Myeloma 1 item
  33. Neuroblastoma 2item
  34. Neuronal Protection 1 item
  35. Non-small Cell Lung Cancer 5item
  36. Ovarian Cancer 4item
  37. Pancreatic Cancer 4item
  38. Prostate Cancer 11item
  39. Psoriasis 1 item
  40. Renal Cancer 1 item
  41. Renal Cell Carcinoma 2item
  42. Rheumatoid Arthritis 3item
  43. Thyroid Cancer 1 item